UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease

Journal of vascular surgery, 1998-02, Vol.27 (2), p.267-275

1998

Volltextzugriff (PDF)

Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlled trial

JAMA : the journal of the American Medical Association, 1999-01, Vol.281 (2), p.137

1999

Volltextzugriff (PDF)

Results from a phase 1 multiple ascending dose study demonstrating safety and selectivity of aldosterone synthase inhibitor CIN-107

European heart journal, 2022-10, Vol.43 (Supplement_2)

2022

Volltextzugriff (PDF)

Comparison of effects of simvastatin versus atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I levels

The American journal of cardiology, 2000-07, Vol.86 (2), p.221-223

2000

Volltextzugriff (PDF)

Serum lipids and incidence of coronary heart disease : Findings from the systolic hypertension in the elderly program (SHEP)

Circulation (New York, N.Y.), 1996-11, Vol.94 (10), p.2381-2388

1996

Volltextzugriff (PDF)

A study of twins and stroke

Stroke (1970), 1992-02, Vol.23 (2), p.221-223

1992

Volltextzugriff (PDF)

Comparison of Efficacy and Safety Assessment of Fluvastatin in Patients <65 Years Versus ≥65 Years of Age

The American journal of cardiology, 2005-10, Vol.96 (8), p.1142-1148

2005

Volltextzugriff (PDF)

Effects of colesevelam HCl on sterol and bile acid excretion in patients with type IIa hypercholesterolemia

Digestive diseases and sciences, 2005-07, Vol.50 (7), p.1232-1238

2005

Volltextzugriff (PDF)

Aggressive lipid-lowering initiation abates new cardiac events (ALLIANCE)—rationale and design of atorvastatin versus usual care in hypercholesterolemic patients with coronary artery disease

The American journal of cardiology, 2000-07, Vol.86 (2), p.250-252

2000

Volltextzugriff (PDF)

Effects of lovastatin therapy on plasminogen activator inhibitor-1 antigen levels

The American journal of cardiology, 1994-10, Vol.74 (7), p.735-737

1994

Volltextzugriff (PDF)

Garlic powder and plasma lipids and lipoproteins: a multicenter, randomized, placebo-controlled trial

Archives of internal medicine (1960), 1998-06, Vol.158 (11), p.1189

1998

Volltextzugriff (PDF)

Efficacy and Safety of Cerivastatin 0.8 mg in Patients with Hypercholesterolaemia: The Pivotal Placebo-Controlled Clinical Trial

Journal of international medical research, 2000-04, Vol.28 (2), p.47-68

2000

Volltextzugriff (PDF)

Effects of Colesevelam HCl on Sterol and Bile Acid Excretion in Patients with Type IIa Hypercholesterolemia

Digestive diseases and sciences, 2005-07, Vol.50 (7), p.1-1

2005

Volltextzugriff (PDF)

Coronary heart disease risk factors in men and women aged 60 years and older : Findings from the systolic hypertension in the elderly program

Circulation (New York, N.Y.), 1996-07, Vol.94 (1), p.26-34

1996

Volltextzugriff (PDF)

Comparison of Efficacy and Safety of Rosuvastatin Versus Atorvastatin in African-American Patients in a Six-Week Trial

The American journal of cardiology, 2006-01, Vol.97 (2), p.229-235

2006

Volltextzugriff (PDF)

Influence of gender on the pharmacokinetics, safety, and tolerability of cerivastatin in healthy adults

European journal of clinical pharmacology, 2001-03, Vol.56 (12), p.897-903

2001

Volltextzugriff (PDF)

Long‐Term Efficacy and Safety of Cerivastatin 0.8 mg in Patients with Primary Hypercholesterolemia

Clinical cardiology (Mahwah, N.J.), 2001-09, Vol.24 (S4), p.1-9

2001

Volltextzugriff (PDF)

Risk reduction and tolerability of fluvastatin in patients with the metabolic syndrome: A pooled analysis of thirty clinical trials

Clinical therapeutics, 2007-09, Vol.29 (9), p.1987-2000

2007

Volltextzugriff (PDF)

Low‐dose combination therapy with colesevelam hydrochloride and lovastatin effectively decreases low‐density lipoprotein cholesterol in patients with primary hypercholesterolemia

Clinical cardiology (Mahwah, N.J.), 2001-06, Vol.24 (6), p.467-474

2001

Volltextzugriff (PDF)

Long-Term Effects of Low-Density Lipoprotein Apheresis Using an Automated Dextran Sulfate Cellulose Adsorption System

The American journal of cardiology, 1998-02, Vol.81 (4), p.407-411

1998

Volltextzugriff (PDF)

Technetium-99m low density lipoproteins: preparation and biodistribution

The Journal of nuclear medicine (1978), 1985-09, Vol.26 (9), p.1056-1062

1985

Volltextzugriff (PDF)

The impact of the national cholesterol education program adult treatment panel III guidelines on drug development

The American journal of cardiology, 2002-03, Vol.89 (5), p.45-49

2002

Volltextzugriff (PDF)

Intraoperative angioscopy: Principles of irrigation and description of a new dedicated irrigation pump

The American heart journal, 1989-08, Vol.118 (2), p.391-399

1989

Volltextzugriff (PDF)

A Comparison of the Safety of Therapeutically Equivalent Doses of Isradipine and Diltiazem for Treatment of Essential Hypertension

American journal of hypertension, 1992-03, Vol.5 (3), p.141-146

1992

Volltextzugriff (PDF)

Frequency of creatine kinase elevation during treatment with fluvastatin

The American journal of cardiology, 2002-01, Vol.89 (2), p.231-233

2002

Volltextzugriff (PDF)

1 – 25 von 63

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(54)
Mit Volltextzugriff
(56)

Publikationsform

Sprache

Englisch
(63)

Erscheinungsjahr

n.n

Thema

Humans
(38)
Life Sciences & Biomedicine
(37)
Science & Technology
(37)
Biological And Medical Sciences
(34)
Medical Sciences
(34)
Male
(31)
Female
(29)
Middle Aged
(28)
Cardiovascular System & Cardiology
(24)
Cardiac & Cardiovascular Systems
(21)
Aged
(18)
Pharmacology. Drug Treatments
(18)
Double-Blind Method
(16)
Adult
(15)
Cholesterol
(14)
General And Cellular Metabolism. Vitamins
(13)
Hypercholesterolemia - Drug Therapy
(12)
Cardiology. Vascular System
(10)
Cholesterol, Ldl - Blood
(10)
Drug Therapy
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease

Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlled trial

Results from a phase 1 multiple ascending dose study demonstrating safety and selectivity of aldosterone synthase inhibitor CIN-107

Comparison of effects of simvastatin versus atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I levels

Serum lipids and incidence of coronary heart disease : Findings from the systolic hypertension in the elderly program (SHEP)

A study of twins and stroke

Comparison of Efficacy and Safety Assessment of Fluvastatin in Patients <65 Years Versus ≥65 Years of Age

Effects of colesevelam HCl on sterol and bile acid excretion in patients with type IIa hypercholesterolemia

Aggressive lipid-lowering initiation abates new cardiac events (ALLIANCE)—rationale and design of atorvastatin versus usual care in hypercholesterolemic patients with coronary artery disease

Effects of lovastatin therapy on plasminogen activator inhibitor-1 antigen levels

Garlic powder and plasma lipids and lipoproteins: a multicenter, randomized, placebo-controlled trial

Efficacy and Safety of Cerivastatin 0.8 mg in Patients with Hypercholesterolaemia: The Pivotal Placebo-Controlled Clinical Trial

Effects of Colesevelam HCl on Sterol and Bile Acid Excretion in Patients with Type IIa Hypercholesterolemia

Coronary heart disease risk factors in men and women aged 60 years and older : Findings from the systolic hypertension in the elderly program

Comparison of Efficacy and Safety of Rosuvastatin Versus Atorvastatin in African-American Patients in a Six-Week Trial

Influence of gender on the pharmacokinetics, safety, and tolerability of cerivastatin in healthy adults

Long‐Term Efficacy and Safety of Cerivastatin 0.8 mg in Patients with Primary Hypercholesterolemia

Risk reduction and tolerability of fluvastatin in patients with the metabolic syndrome: A pooled analysis of thirty clinical trials

Low‐dose combination therapy with colesevelam hydrochloride and lovastatin effectively decreases low‐density lipoprotein cholesterol in patients with primary hypercholesterolemia

Long-Term Effects of Low-Density Lipoprotein Apheresis Using an Automated Dextran Sulfate Cellulose Adsorption System

Technetium-99m low density lipoproteins: preparation and biodistribution

The impact of the national cholesterol education program adult treatment panel III guidelines on drug development

Intraoperative angioscopy: Principles of irrigation and description of a new dedicated irrigation pump

A Comparison of the Safety of Therapeutically Equivalent Doses of Isradipine and Diltiazem for Treatment of Essential Hypertension

Frequency of creatine kinase elevation during treatment with fluvastatin

Suchergebnisse filtern